Highlights J. Molner

Equities

MOLNRIPO

EE3100109034

Market Closed - Nasdaq Tallinn Other stock markets 08:43:59 2024-05-17 am EDT			5-day change	1st Jan Change
14.3 ^EUR	-0.69%		-0.69%	+4.00%

Apr. 30	J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%	CI
Mar. 04	J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%	Apr. 30	CI
J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	Mar. 04	CI
J. Molner AS Signs Licensing Agreement for Five Approved Drugs in the US	23-09-06	CI
J. Molner AS has completed an IPO in the amount of Ã‡1.199998 million.	22-11-07	CI
J. Molner AS has filed an IPO in the amount of Ã‡1.199998 million.	22-10-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW